Elevance Health, Inc.
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Total Carelon (CarelonRx + Carelon Services) by Year
Total Carelon (CarelonRx + Carelon Services) — Operating Revenue ($M)
Elevance Health Total Carelon (CarelonRx + Carelon Services): $71,716M in FY2025, up 33.0% from a year earlier.
Where the FY2025 figure comes from
“|| Operating revenue - total | $ | 167,094 | $ | 43,400 | $ | 28,316 | $ | 71,716 | $ | 463 | $ | ( 41,689 ) | $ | 197,584”
Source: 10-K (FY2025, 2026-02-06) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Carelon (CarelonRx + Carelon Services) — Operating Revenue ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 71,716 | +33.0% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2024 | Dec 31, 2024 | 53,922 | +12.4% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2023 | Dec 31, 2023 | 47,982 | +15.9% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2022 | Dec 31, 2022 | 41,386 | +16.4% | 10-K (FY2024, 2025-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 35,561 | – | 10-K (FY2023, 2024-02-21) ↗ |
Breakdown
What makes up total Carelon (CarelonRx + Carelon Services)
- CarelonRx Segment — Total Operating Revenue43,400 · FY2025
- Carelon Services Segment — Total Operating Revenue28,316 · FY2025
- Total Carelon — Unaffiliated (External Third-Party) Operating Revenue31,624 · FY2025
- Total Carelon — Affiliated (Intersegment) Operating Revenue40,092 · FY2025
- Total Carelon — Segment Benefit Expense (ASU 2023-07)24,283 · FY2025
- Total Carelon — Cost of Products Sold (ASU 2023-07)40,077 · FY2025
- Total Carelon — Segment Operating Expense (ASU 2023-07)3,978 · FY2025
Cite this data
StockData. (2026). Elevance Health Total Carelon (CarelonRx + Carelon Services) ($M), annual FY2021–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-rev-carelon-total
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.